HIV infection of primary CD4+ Th2 cells, defined by expression of the chemoattractant receptor-homologous (CRTH2), induces a Th0 phenotype

被引:5
作者
Bahbouhi, Bouchaib
Landay, Alan
Tenorio, Allan
Al-Harthi, Lena
机构
[1] Rush Univ, Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA
[2] Rush Univ, Med Ctr, Infect Dis Sect, Chicago, IL 60612 USA
关键词
D O I
10.1089/aid.2006.0151
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The association between HIV, cytokine profile, and disease progression is controversial. In this study, we evaluated whether HIV infection of a primary T helper-like type 2 cytokine (Th2) cell subset augments their cytokine profile. We utilized the CRTH2 ( chemoattractant receptor-homologous) marker to identify CD4(+)Th2 cells. Approximately 2-4% of CD4(+) T cells are CRTH2(+). CRTH2(+) expression is confirmed to delineate a Th2 subset as indicated by robust inducible IL-4 response. CD4(+) CRTH2(+) T cells were also more inherently activated than their CRTH2-negative counterpart as indicated by a higher percent expression of CD69, CD45RO, CD95, CD25, and HLA-DR. CD4(+)CRTH2(+) T cells were not terminally differentiated as indicated by expression of CD27 and CD28. In vitro HIV infection of primary human CD4(+) CRTH2(+) T cells, independent of chemokine coreceptor usage, potently upregulated IFN-gamma production while still maintaining robust IL-4 expression. This Th0 (IFN gamma+IL-4(+)) phenotype was upregulated in CD4(+)CRTH2(+) T cells post-HIV infection by 18-fold, demonstrating a shift to a Th0 phenotype. Ex vivo studies also demonstrated that HIV+ patients exhibited a decline in CD4(+)CRTH2(+) cells and a shift of this population toward cells that express both IFN-gamma and IL-4. Collectively, these data indicate that HIV replication in Th2 cells induces a Th0 phenotype. This phenomenon may be a deliberate viral escape mechanism to prevent the skewing of the immune response toward Th1 or Th2.
引用
收藏
页码:269 / 277
页数:9
相关论文
共 28 条
[1]   Induction of HIV-1 replication by type I-like cytokines, interleukin (IL)-12 and IL-15: Effect on viral transcriptional activation, cellular proliferation, and endogenous cytokine production [J].
Al-Harthi, L ;
Roebuck, KA ;
Landay, A .
JOURNAL OF CLINICAL IMMUNOLOGY, 1998, 18 (02) :124-131
[2]   Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease [J].
Al-Harthi, L ;
Siegel, J ;
Spritzler, J ;
Pottage, J ;
Agnoli, M ;
Landay, A .
AIDS, 2000, 14 (07) :761-770
[3]   Immune recovery in HIV disease: Role of the thymus and T cell expansion in immune reconstitution strategies [J].
Al-Harthi, L ;
Landay, A .
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2002, 11 (05) :777-786
[4]   Inhibition of cytokine-driven human immunodeficiency virus type 1 replication by protease inhibitor [J].
AlHarthi, L ;
Roebuck, KA ;
Kessler, H ;
Landay, A .
JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (05) :1175-1179
[5]   HIV-1 Tat induces the expression of the interleukin-6 (IL6) gene by binding to the IL6 leader RNA and by interacting with CAAT enhancer-binding protein beta (NF-IL6) transcription factors [J].
Ambrosino, C ;
Ruocco, MR ;
Chen, XN ;
Mallardo, M ;
Baudi, F ;
Trematerra, S ;
Quinto, I ;
Venuta, S ;
Scala, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (23) :14883-14892
[6]  
Annunziato F, 2001, J ALLERGY CLIN IMMUN, V108, P815
[7]   Dynamics of cytokine expression in HIV productively infected primary CD4+ T cells [J].
Bahbouhi, B ;
Landay, A ;
Al-Harthi, L .
BLOOD, 2004, 103 (12) :4581-4587
[8]   TYPE-1 TYPE-2 CYTOKINE MODULATION OF T-CELL PROGRAMMED CELL-DEATH AS A MODEL FOR HUMAN-IMMUNODEFICIENCY-VIRUS PATHOGENESIS [J].
CLERICI, M ;
SARIN, A ;
COFFMAN, RL ;
WYNN, TA ;
BLATT, SP ;
HENDRIX, CW ;
WOLF, SF ;
SHEARER, GM ;
HENKART, PA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (25) :11811-11815
[9]   A T(H)1-]T(H)2 SWITCH IS A CRITICAL STEP IN THE ETIOLOGY OF HIV-INFECTION [J].
CLERICI, M ;
SHEARER, GM .
IMMUNOLOGY TODAY, 1993, 14 (03) :107-110
[10]   CHANGES IN INTERLEUKIN-2 AND INTERLEUKIN-4 PRODUCTION IN ASYMPTOMATIC, HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE INDIVIDUALS [J].
CLERICI, M ;
HAKIM, FT ;
VENZON, DJ ;
BLATT, S ;
HENDRIX, CW ;
WYNN, TA ;
SHEARER, GM .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (03) :759-765